Purpose: Aberrant overexpression of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v has been found in numerous human cancers. The goal of this study was to characterize the functions of GRB7 and GRB7v in the ovarian carcinogenesis and to investigate the differential roles of GRB7 and GRB7v in the modulation of signaling pathways.Experimental Design: Quantitative reverse transcription-PCR, Western blot, and immunohistochemical analyses were used to evaluate the levels of GRB7 and GRB7v. The cellular localization, functions, and signaling pathways regulated by GRB7 and GRB7v were investigated by enforced expression of GRB7 and GRB7v.Results: Quantitative reverse transcription-PCR and Western blot analyses showed that GRB7 and GRB7v were frequently upregulated in ovarian cancer samples. The overexpressed GRB7 (P = 0.009) and GRB7v (P = 0.017) were significantly correlated with high-grade ovarian cancer. Immunohistochemical analysis on ovarian cancer tissue array confirmed that the upregulated GRB7 was significantly correlated with high-grade ovarian cancer (P = 0.001). Confocal microscopy analysis showed that GRB7 and GRB7v predominately localized in cytoplasm of ovarian cancer cells, consistent with their roles as signaling adaptors. Enforced expression of GRB7 promoted cell proliferation, migration, and invasion, whereas GRB7v only increased cell proliferation and anchorage-independent growth ability. With the treatment of specific kinase inhibitors, we showed that both GRB7 and GRB7v promoted cell proliferation through activating extracellular signal-regulated kinase signaling, whereas GRB7 enhanced cell migration/invasion by activating c-Jun NH 2 terminal kinase signaling.Conclusions: Our studies implicate that the overexpressed GRB7 and GRB7v are associated with highgrade tumors and exert distinct tumorigenic functions through regulating different signaling pathways in ovarian cancer cells. Clin Cancer Res; 16(9); 2529-39. ©2010 AACR.Ovarian cancer is one of the most deadly malignancies in women (1). Approximately 70% of ovarian cancer cases are diagnosed at the advanced stage, and the mortality rate has remained high for decades (2). It is widely accepted that genetic variations act in concert with other factors, such as hormonal and environmental factors, to potentiate the risk of ovarian cancer. However, the knowledge on the molecular basis of ovarian cancer development remains poor (3). Undoubtedly, a better understanding of the molecular pathogenesis of ovarian cancer may assist the development of novel therapeutic interventions for this disease.Tyrosine kinase signaling pathways are the major regulators of cell growth, cell division, and motility. The aberrant activation of these pathways attributes to the development of many human cancers (4, 5). The human growth factor receptor-bound protein 7 (GRB7) is a member of GRB7 adaptor protein family, which also includes GRB10 and GRB14, and acts as an adaptor bridging the growth factor receptor kinase proteins and their downstream ...